ClinicalTrials.Veeva

Menu
C

Core Research Group Pty Ltd | Brisbane, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Povetacicept
INS068
Tirzepatide
ABP-745
LY3298176

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials
New

A Phase II Study to Evaluate the Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of...

Begins enrollment in 1 month
ASCVD Management
Atherosclerosis Cardiovascular Disease
Drug: ABP-745 Dose B
Drug: Placebo

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Active, not recruiting
Immunoglobulin A Nephropathy
Drug: Placebo (matched to Povetacicept)
Drug: Povetacicept

Trial sponsors

Hengrui Medicine logo
Lilly logo
R
A
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems